Cambridge Cognition Holdings Plc Market Cap ($180.62K)
Market Cap & Net Worth: Cambridge Cognition Holdings Plc (COG)
Cambridge Cognition Holdings Plc market cap. Cambridge Cognition Holdings Plc (LSE:COG) has a market capitalization of $180.62K (GBX1.48 Billion) as of November 4, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31382 globally and #1033 in its home market, demonstrating a -1.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cambridge Cognition Holdings Plc's stock price GBX27.50 by its total outstanding shares 53981413 (53.98 Million). Also see Cambridge Cognition Holdings Plc cash flow conversion for how efficiently the company converts equity into cash flow.
Cambridge Cognition Holdings Plc Market Cap History (2015–2026)
Cambridge Cognition Holdings Plc market cap history from 2015 to 2026. Data shows change from $545.14K to $180.62K (-9.99% CAGR). Check current stock price of Cambridge Cognition Holdings Plc for real-time trading data and today's change.
Index Memberships
Cambridge Cognition Holdings Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$993.59 Million | 0.02% | #296 of 722 |
Weight: Cambridge Cognition Holdings Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cambridge Cognition Holdings Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cambridge Cognition Holdings Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Cambridge Cognition Holdings Plc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
Cambridge Cognition Holdings Plc's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $453.19K | $6.88 Million | $272.00K | 0.07x | 1.67x |
| 2017 | $1.04 Million | $6.73 Million | -$257.00K | 0.16x | N/A |
| 2018 | $545.14K | $6.13 Million | -$1.44 Million | 0.09x | N/A |
| 2019 | $183.90K | $5.04 Million | -$2.90 Million | 0.04x | N/A |
| 2020 | $440.05K | $6.74 Million | -$438.00K | 0.07x | N/A |
| 2021 | $830.85K | $10.09 Million | $450.00K | 0.08x | 1.85x |
| 2022 | $748.75K | $12.61 Million | -$409.00K | 0.06x | N/A |
| 2023 | $338.25K | $13.52 Million | -$3.51 Million | 0.03x | N/A |
| 2024 | $246.30K | $10.34 Million | -$1.78 Million | 0.02x | N/A |
| 2025 | $183.90K | $9.40 Million | -$1.68 Million | 0.02x | N/A |
Competitor Companies of COG by Market Capitalization
Companies near Cambridge Cognition Holdings Plc in the global market cap rankings as of November 4, 2026. Also see Cambridge Cognition Holdings Plc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Cambridge Cognition Holdings Plc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #718 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1660 globally with a market cap of $14.14 Billion USD ( AU$19.99 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2013 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #718 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $303.21 |
| #1660 | Pro Medicus Ltd | AU:PME | $14.14 Billion | AU$191.33 |
| #2013 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $77.80 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $69.84 |
Market Capitalization of Cambridge Cognition Holdings Plc (2015–2026)
Market capitalization of Cambridge Cognition Holdings Plc from 2015 to today. Between 2015 and today, Cambridge Cognition Holdings Plc's market cap moved from $545.14K to $ 180.62K, with a yearly change of -9.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX180.62K | -1.79% |
| 2025 | GBX183.90K | -25.33% |
| 2024 | GBX246.30K | -27.18% |
| 2023 | GBX338.25K | -54.82% |
| 2022 | GBX748.75K | -9.88% |
| 2021 | GBX830.85K | +88.81% |
| 2020 | GBX440.05K | +139.29% |
| 2019 | GBX183.90K | -66.27% |
| 2018 | GBX545.14K | -47.80% |
| 2017 | GBX1.04 Million | +130.43% |
| 2016 | GBX453.19K | -16.87% |
| 2015 | GBX545.14K | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Cambridge Cognition Holdings Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $180.62K USD |
| MoneyControl | $180.62K USD |
| MarketWatch | $180.62K USD |
| marketcap.company | $180.62K USD |
| Reuters | $180.62K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers sensitive, precise and objective measures of cognitive function, correlated to neural networks; voice analysis, an automated speech recognition tool for monitoring neurological and psychiatric d… Read more